Private Advisor Group, LLC Novo Nordisk A S Transaction History

Private Advisor Group, LLC

$17.4 Billion
Q4 2024

A detailed history of Private Advisor Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Private Advisor Group, LLC holds 77,840 shares of NVO stock, worth $7.06 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

77,840

Previous 93,063 16.36%

Holding current value

$7.06 Million

Previous $11.1 Million 39.58%

% of portfolio

0.04%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$85.0 - $120.04 $1.29 Million - $1.83 Million	-15,223 Reduced 16.36%	77,840 $6.7 Million
Q3 2024 Oct 22, 2024	SELL	$119.07 - $145.42 $127,881 - $156,181	-1,074 Reduced 1.14%	93,063 $11.1 Million
Q2 2024 Aug 05, 2024	SELL	$122.71 - $146.91 $109,702 - $131,337	-894 Reduced 0.94%	94,137 $13.4 Million
Q1 2024 Apr 30, 2024	SELL	$102.11 - $135.92 $14,908 - $19,844	-146 Reduced 0.15%	95,031 $12.2 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $204,966 - $246,225	2,335 Added 2.52%	95,177 $9.85 Million
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $4.38 Million - $9.62 Million	48,216 Added 108.04%	92,842 $8.44 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $69,255 - $76,656	444 Added 1.0%	44,626 $7.22 Million
Q1 2023 May 10, 2023	BUY	$132.34 - $159.14 $301,602 - $362,680	2,279 Added 5.44%	44,182 $7.03 Million
Q4 2022 Jan 18, 2023	BUY	$102.55 - $135.33 $127,469 - $168,215	1,243 Added 3.06%	41,903 $0
Q3 2022 Oct 14, 2022	SELL	$95.28 - $116.93 $2.16 Million - $2.65 Million	-22,699 Reduced 35.83%	40,660 $4.05 Million
Q2 2022 Jul 13, 2022	BUY	$103.24 - $121.81 $409,036 - $482,611	3,962 Added 6.67%	63,359 $7.06 Million
Q1 2022 May 12, 2022	BUY	$93.1 - $112.54 $117,864 - $142,475	1,266 Added 2.18%	59,397 $6.6 Million
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $3.58 Million - $4.38 Million	-37,379 Reduced 39.14%	58,131 $6.51 Million
Q3 2021 Oct 14, 2021	BUY	$84.42 - $106.62 $3.54 Million - $4.48 Million	41,991 Added 78.46%	95,510 $9.17 Million
Q2 2021 Aug 12, 2021	BUY	$67.66 - $84.76 $195,808 - $245,295	2,894 Added 5.72%	53,519 $4.48 Million
Q1 2021 Apr 22, 2021	BUY	$67.06 - $75.82 $550,964 - $622,937	8,216 Added 19.37%	50,625 $3.41 Million
Q4 2020 Apr 01, 2021	BUY	$63.89 - $73.8 $377,462 - $436,010	5,908 Added 16.19%	42,409 $2.96 Million
Q3 2020 Nov 02, 2020	BUY	$63.69 - $70.22 $149,480 - $164,806	2,347 Added 6.87%	36,501 $2.44 Million
Q2 2020 Aug 17, 2020	SELL	$58.54 - $67.94 $302,066 - $350,570	-5,160 Reduced 13.13%	34,154 $2.24 Million
Q1 2020 May 12, 2020	BUY	$49.46 - $64.78 $101,491 - $132,928	2,052 Added 5.51%	39,314 $2.37 Million
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $20,642 - $24,119	414 Added 1.12%	37,262 $2.16 Million
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $285,715 - $321,114	6,010 Added 19.49%	36,848 $1.99 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $800,155 - $897,289	17,101 Added 124.49%	30,838 $1.57 Million
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $1.09 Million - $1.24 Million	-23,505 Reduced 63.11%	13,737 $709,000
Q4 2018 Feb 11, 2019	BUY	$41.54 - $47.25 $988,652 - $1.12 Million	23,800 Added 177.06%	37,242 $1.72 Million
Q3 2018 Nov 01, 2018	SELL	$46.76 - $51.24 $1.01 Million - $1.1 Million	-21,527 Reduced 61.56%	13,442 $634,000
Q2 2018 Aug 09, 2018	BUY	$44.29 - $50.42 $1.3 Million - $1.48 Million	29,297 Added 516.52%	34,969 $1.62 Million
Q1 2018 May 09, 2018	SELL	$48.49 - $58.14 $208,507 - $250,002	-4,300 Reduced 43.12%	5,672 $279,000
Q4 2017 Feb 07, 2018	SELL	$47.53 - $53.73 $189,502 - $214,221	-3,987 Reduced 28.56%	9,972 $541,000
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $95,879 - $114,682	2,330 Added 20.04%	13,959 $683,000
Q2 2017 Aug 10, 2017	BUY	N/A	11,629	11,629 $491,000

Others Institutions Holding NVO

# of Institutions

1,884

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $205B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Novo Nordisk A S Transaction History